Warning: This security is no longer trading.
defunct
Neuralstem, Inc. (CUR): Price and Financial Metrics
CUR Price/Volume Stats
| Current price | $1.52 | 52-week high | $13.78 |
| Prev. close | $1.83 | 52-week low | $1.10 |
| Day low | $1.48 | Volume | 2,097,100 |
| Day high | $1.81 | Avg. volume | 236,278 |
| 50-day MA | $1.55 | Dividend yield | N/A |
| 200-day MA | $6.25 | Market Cap | 3.19M |
CUR Stock Price Chart Interactive Chart >
Neuralstem, Inc. (CUR) Company Bio
Neuralstem, Inc., a clinical stage biopharmaceutical company, focuses on the research and development of nervous system therapies based on its proprietary human neuronal stem cells and small molecule compounds. The companys stem cell based technology enables the isolation and expansion of human neural stem cells from various areas of the developing human brain and spinal cord enabling the generation of physiologically relevant human neurons of various types. The company was founded in 1996 and is based in Germantown, Maryland.
CUR Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | -83.48% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | 0.00% |
Loading social stream, please wait...